CompletedPhase 3NCT03621280
Open-label Treatment in Cushing's Syndrome
Studying Adrenal Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cortendo AB
- Principal Investigator
- Fredric Cohen, MD, M.DCortendo AB
- Intervention
- Levoketoconazole(drug)
- Enrollment
- 51 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2022
Study locations (30)
- The Center for Diabetes and Endocrine Care, Fort Lauderdale, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- University of New Mexico HSC - HSC Sponsored Projects Office, Albuquerque, New Mexico, United States
- Columbia University Medical Center, New York, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Oregon Health & Science University, Portland, Oregon, United States
- Sveti Georgy University Hospital Clinic of Endocrinology and Metabolic Diseases, Plovdiv, Bulgaria
- Alexandovska University Hospital, Sofia, Bulgaria
- University Specialized Hospital for Active Treatment in Endocrinology, Sofia, Bulgaria
- APHM Hôpital de la Conception, Marseille, France
- General Hospital of Athens Evangelismos Department of Endocrinology and Diabete, Athens, Greece
- Hippokration General Hospital Endocrinology and Diabetes Department, Thessaloniki, Greece
- Semmelweis Egyetem II. Belgyógyászati Klinika, Budapest, Hungary
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03621280 on ClinicalTrials.govOther trials for Adrenal Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07168122Establishment and Clinical Application of Reference Intervals of Salivary CortisolShanghai 6th People's Hospital
- RECRUITINGNANCT06250699A Single Center Randomized Controlled Study on the Promotion of Rapid RecoveryZhe Meng
- RECRUITINGNANCT05911620Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous HypercorticismCentral Hospital, Nancy, France
- RECRUITINGNANCT05881005NAC- NAFLD and CushingUniversity Hospital, Angers
- RECRUITINGNCT06050057Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyUniversity Hospital Olomouc
- RECRUITINGNCT05521529Cushing's Syndrome Before and After Treatment (CORRECT)University of Aarhus
- ACTIVE NOT RECRUITINGNCT05446779Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden DeathHelsinki University Central Hospital
- RECRUITINGPHASE2NCT03708900Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's SyndromeRECORDATI GROUP